ALICIA D SCOGGINS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care WOODVILLE, TX NPI 1407899495
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care TX GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$696.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $176.95 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.95 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $44.12 | 2 |
| ABBVIE INC. | $42.31 | 2 |
| Acerta Pharma LLC | $35.69 | 2 |
| Novo Nordisk AS | $19.21 | 1 |
| PFIZER INC. | $19.02 | 1 |
| Lilly USA, LLC | $16.60 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100337015 | Novo Nordisk Inc | $19.21 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104374685 | AstraZeneca Pharmaceuticals LP | $15.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105629758 | AstraZeneca Pharmaceuticals LP | $20.03 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108165016 | ABBVIE INC. | $18.42 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108165018 | ABBVIE INC. | $23.89 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116487401 | GlaxoSmithKline, LLC. | $26.80 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116624821 | GlaxoSmithKline, LLC. | $17.32 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131984143 | PFIZER INC. | $19.02 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135485225 | Lilly USA, LLC | $16.60 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.